Omadacycline for the Treatment of Severe Chlamydia psittaci Pneumonia Complicated with Multiple Organ Failure: A Case Report
Open Access
- 4 October 2022
- journal article
- case report
- Published by Taylor & Francis in Infection and Drug Resistance
- Vol. ume 15, 5831-5838
Abstract
Psittacosis is a rare zoonotic disease caused by Chlamydia psittaci infection, and tetracyclines are the preferred treatment. Omadacycline is a novel tetracycline that has a strong in vitro antibacterial activity against atypical pathogens, including C. psittaci; however, clinical data for its usage are lacking. We report a patient with severe C. psittaci-induced pneumonia presenting with a high fever, muscle aches, severe hepatic and renal insufficiency, and acute respiratory failure requiring tracheal intubation and mechanical ventilation. The condition was diagnosed using metagenomic next-generation sequencing. The patient was discharged after treatment with omadacycline. The findings of this study suggest that metagenomic next-generation sequencing is valuable for the rapid and accurate diagnosis of psittacosis. With its good safety profile and no requirement for dose adjustment in special populations, omadacycline is a new option for the treatment of severe C. psittaci pneumonia. However, additional case reports are needed to support this conclusion.Keywords
This publication has 25 references indexed in Scilit:
- Omadacycline for Community-Acquired Bacterial PneumoniaNew England Journal of Medicine, 2019
- In Vitro Activity of Omadacycline against Chlamydia pneumoniaeAntimicrobial Agents and Chemotherapy, 2019
- Chlamydia psittaci(psittacosis) as a cause of community-acquired pneumonia: a systematic review and meta-analysisEpidemiology and Infection, 2017
- Compendium of Measures to ControlChlamydia psittaciInfection Among Humans (Psittacosis) and Pet Birds (Avian Chlamydiosis), 2017Journal of Avian Medicine and Surgery, 2017
- Comparison of Omadacycline and Tigecycline Pharmacokinetics in the Plasma, Epithelial Lining Fluid, and Alveolar Cells of Healthy Adult SubjectsAntimicrobial Agents and Chemotherapy, 2017
- Diagnosis and treatment of community‐acquired pneumonia in adults: 2016 clinical practice guidelines by the Chinese Thoracic Society, Chinese Medical AssociationThe Clinical Respiratory Journal, 2017
- Clinical disposition, metabolism andin vitrodrug–drug interaction properties of omadacyclineXenobiotica, 2016
- Community-acquired pneumonia related to intracellular pathogensIntensive Care Medicine, 2016
- Systematic Review and Meta-Analysis: Macrolides- and Amoxicillin/Clavulanate-induced Acute Liver InjuryBasic & Clinical Pharmacology & Toxicology, 2015
- Chlamydia psittaci: update on an underestimated zoonotic agentPathogens and Disease, 2014